Eminence Business Media - A Eminence Group Company’s Post

Stepping Into the Role of Group Operations Director at TM Pharma Group I admit my LinkedIn activity is rather sporadic, but with a new chapter starting as the Group Operations Director at TM Pharma Group (TMPG), it felt the time was right to share a brief update. The last couple of years have been really eventful for us. Following my wife, Tracy Moore's departure from the MHRA post-pandemic, the need for her expertise became ever more apparent. Setting up TMPG, led to rapid expansion to 16 countries, with new pins on the map each week! My path to TMPG appears unconventional, yet to me, it aligns perfectly to industry needs. While Pharma innovators develop crucial treatments, the support services that underpin this process can slow their stride. My role ensures these services are part of the very fabric contributing to the main act of safe product design and delivery. Security of our team is a serious matter. We operate in complex times, and I've seen many instances where more security foresight, could have spared a great deal of trouble. A recent case in point: colleagues in another industry found themselves detained in a precarious situation overseas, despite being on a government-backed project. A reminder we must always be proactive about safety. Rest assured, safeguarding our people and ensuring our operations run smoothly is something I take very personally. I am lucky in many respects that TM Pharma started with the highest standards at the centre of everything it does, therefore my role is to maintain and improve those standards wherever we can (no pressure – its my wife’s company after all!). I have always acknowledged that others may be doing things in a way that sets a benchmark, and failing to recognise that can lead down a path of failure, so I come to the industry with very open eyes, adding my expertise where its needed, and learning from others as I go. As Steve Jobs once famously said, ‘you don’t employ experts to tell them what to do”… Our partnerships are built on trust, and we can count many of them as friends. This can only come when there is a mutual trust built around the same goals and objectives. Above all of them is the shared goal of patient safety. You may have noticed that our most recent partnership is with RegDev Inc. We have some exciting plans ahead with RegDev and we look forward to what the future holds. If you feel that you’d like to talk to us about mutual interests, drop us a line, or catch us at one of the many events we try and attend when work allows. I am looking forward to steering our operations forward, where expertise and innovation are not just buzzwords, but cemented as the very pillars of our workflow. It's the combined efforts of my wife, Tracy and our stellar team that have positioned us where we are, and I am excited to build on this foundation, ensuring that together, we continue to set industry benchmarks. Enough from me now and please feel free to connect, Tony – out…

Traditional pharmaceutical companies struggle to blend digital transformation with their regulatory-focused business models, a challenge SINGULIER actively helps our clients in healthcare and pharma overcome - as in the case of HRA Pharma.     We're proud to have partnered with HRA Pharma, now a part of Perrigo Company plc, in revolutionising their digital marketing and customer acquisition strategies. In the run up to Perrigo's acquisition in 2021, they began shifting gears to a digital-first mindset and enlisted the help of Singulier to enhance HRA Pharma's online presence across various e-commerce channels.     The outcomes were outstanding:     📈 Up to 45% Year-on-Year (YOY) increase in clicks   🌐 +40% YOY rise in website engagement   💷 -5% YOY reduction in Cost Per Click (CPC)     A heartfelt thanks to the teams at Perrigo and HRA Pharma especially to Stella Panetta, Anja Walz, Martina Gripp, MBA, Céline Dehesdin, Yasmine Anouar, Needhi Mehta, David Reilly and team for their collaboration in this successful venture.      Wondering how we got there? Read the case study by clicking on the link in the comments.    #DigitalExcellence #HealthcareInnovation #CollaborativeSuccess #Singulier #Casestudy #Digitaltransformation   

𝐏𝐞𝐫𝐦𝐢𝐫𝐚 𝐀𝐧𝐧𝐨𝐮𝐧𝐜𝐞𝐬 𝐒𝐮𝐛𝐬𝐭𝐚𝐧𝐭𝐢𝐚𝐥 𝐈𝐧𝐯𝐞𝐬𝐭𝐦𝐞𝐧𝐭 𝐢𝐧 𝐏𝐡𝐚𝐫𝐦𝐚𝐂𝐨𝐫𝐝 A leading provider of patient services for the pharma industry, PharmaCord’s CEO, Nitin Sahney, will continue to lead the company, with the management team remaining significant investors. The deal, set to close by the end of Q4 2024, aims to expand PharmaCord's tech-enabled offerings and support its ambitious growth plans. What's important about this type of activity, is that we're starting to see more of these updates in the lead-up to what I expect to be a broader shift in the market. The sentiment from our partners across this space is that deal activity is very high currently, probably the highest it has been in 2024 and for some dating back further. It's fair to say we've been waiting for the deal market to bounce back, and I'd like to think that this is just one example showing that we are moving in the right direction moving into the second half of this year. #LifeSciences #PrivateEquity #Healthcare

How to drive value through #media efficiency in #healthcare and #pharmaceuticals, sectors significantly impacted by digitalisation? Journeys are more and more digitalised in both healthcare and pharmaceuticals: discovery, search, ordering or appointments booking, etc. Discover our case study with Perrigo by clicking on this link: https://lnkd.in/eV-bQ6ir #Media #ValueCreation 🚀🚀🚀

As nice as it was to have a decent length break over the Xmas and NY period, and spend some quality time with family and friends, wasn't it nice to re-engage the old brain cells in work again from either late last week or in my case, yesterday (6th Jan)? Pharma tends to shut down over Xmas so it was a case of the usual rush to finish projects, raise final invoices and make sure all the details were pinned down before being able to sign off. I really enjoyed yesterday, re-engaging with colleagues, revisiting live proposals and contracts, and generally spinning myself back up again ready for the week to come. Looking forward to reconnecting with clients and making lots of new connections now we're back. As always, if you'd like to kick anything Insights related (primary, secondary, GTM, SFE) around as you spin yourself back into work mode we're around and always happy to chat and offer viewpoints / advice :) Have a great first week! (Looks like I have forgotten how to use the LI emojis now, so please bear with!!)

Last week we had the pleasure of welcoming our new SK pharmteco Global Head of Operational Excellence Kathryn Gardner on our #cellandgenetherapy EU Site Yposkesi, an SK pharmteco company. A day of discussions on our particularly important OE journey #cdmo in order to be able to satisfy our customers and our employees even better. Welcome on board Kathryn ! #operationalexcellence #OE #viralvector #industrialmindset #customersatisfaction #leansixsigma #operations #projectmanagement

💡 Did you know that in 2024, 96% of new U.S. energy capacity will be carbon-free, led by solar and battery storage? Find out more about this, and other industry research the team has been working on 👇🤓

We're pleased to announce the acquisition of Propan, a leading brand in multivitamins and appetite stimulants, from ADP Pharma Corporation. Propan has been a trusted brand in the Philippines for years, helping people of all ages live healthier lives. Prior to the acquisition, we have been responsible for the commercialization and distribution of Propan in the Philippines since 2018. This acquisition marks a significant step forward in our expansion into the consumer health segment, enabling us to strategically innovate and better address the evolving healthcare needs of Asia. Read more on the acquisition in the press release here: https://lnkd.in/gx3a3gSD #ZuelligPharma #Propan #Commercialization #ConsumerHealthcare #MakingHealthcareMoreAccessible

The journey of Medika Natura Sdn Bhd began in 2006 with a bold vision: transforming Malaysia’s natural resources into globally recognized bioactive solutions within the life sciences industry. From navigating early funding challenges to securing patents and regulatory approvals, the path was marked by resilience and innovation. Building scientific credibility, forming strategic partnerships, and competing in markets dominated by established players required relentless dedication. Despite setbacks, Medika Natura achieved milestones like FDA and EFSA clearances, multi-center, multi-country clinical trials, and international market expansion. As we step into the New Year, Medika Natura is embarking on an exciting new chapter. Moving into our new office symbolizes more than just a change in space—it reflects our commitment to scaling up our global reach and solidifying our position as a transformative force in life sciences and natural therapeutics. With robust foundations in science, regulatory success, and clinical validation, we are poised to expand into new markets, foster international collaborations, and redefine healthcare solutions. This year marks our transformation into a truly global company, driven by innovation, sustainability, and a relentless dedication to improving lives worldwide. The journey continues! #goglobal

⭐️Check out our joint article on the key to culture conscious pharma partnerships below ⬇️ ⭐️To discuss collaboration opportunities and to learn how Galen can add value to your product launch- get in touch today! 📈